CA2363684A1 - Proteines de secretion humaines - Google Patents

Proteines de secretion humaines Download PDF

Info

Publication number
CA2363684A1
CA2363684A1 CA002363684A CA2363684A CA2363684A1 CA 2363684 A1 CA2363684 A1 CA 2363684A1 CA 002363684 A CA002363684 A CA 002363684A CA 2363684 A CA2363684 A CA 2363684A CA 2363684 A1 CA2363684 A1 CA 2363684A1
Authority
CA
Canada
Prior art keywords
hsecp
polynucleotide
sequence
polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002363684A
Other languages
English (en)
Inventor
Y. Tom Tang
Preeti Lal
Mariah R. Baughn
Henry Yue
Janice Au-Young
Dyung Aina M. Lu
Yalda Azimzai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2363684A1 publication Critical patent/CA2363684A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des protéines de sécrétion humaines (HSECP) et des polynucléotides identifiant et codant pour lesdites protéines (HSECP). L'invention a trait également à des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et antagonistes. Enfin, l'invention a pour objet des méthodes de diagnostic, de traitement, ou de prévention des troubles associés à l'expression desdites protéines (HSECP).
CA002363684A 1999-03-05 2000-03-03 Proteines de secretion humaines Abandoned CA2363684A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12311799P 1999-03-05 1999-03-05
US60/123,117 1999-03-05
PCT/US2000/005621 WO2000052151A2 (fr) 1999-03-05 2000-03-03 Proteines de secretion humaines

Publications (1)

Publication Number Publication Date
CA2363684A1 true CA2363684A1 (fr) 2000-09-08

Family

ID=22406805

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002363684A Abandoned CA2363684A1 (fr) 1999-03-05 2000-03-03 Proteines de secretion humaines

Country Status (5)

Country Link
EP (1) EP1165766A2 (fr)
JP (1) JP2002537805A (fr)
AU (1) AU3393900A (fr)
CA (1) CA2363684A1 (fr)
WO (1) WO2000052151A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7414112B2 (en) 1998-10-08 2008-08-19 Genentech, Inc. Antibodies to PRO1550 polypeptides
EP1702928A3 (fr) * 2000-06-02 2006-09-27 Genentech, Inc. Polypeptides secrétées ou transmembranaire, ainsi que les acides nucléiques qui les codent
US7335731B2 (en) 2000-07-25 2008-02-26 Genentech, Inc. PRO4332 polypeptides
EP1666490A3 (fr) * 2000-07-25 2006-11-02 Genentech, Inc. Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
US6630325B1 (en) * 2000-10-19 2003-10-07 Maine Medical Center Research Institute Compositions, methods and kits relating to remodel
US20040166500A1 (en) * 2001-01-16 2004-08-26 Panzer Scott R Secretory molecules
EP2305710A3 (fr) 2002-06-03 2013-05-29 Genentech, Inc. Bibliothèques de phages et anticorps synthétiques
EP1546171A4 (fr) * 2002-08-14 2008-01-02 Lg Life Sciences Ltd Familles de genes liees au cancer gastrique
WO2004060867A2 (fr) * 2003-01-02 2004-07-22 Timothy Kirk Gallaher Facteur proteine secrete et variant d'epissure membranaire
CN102517381A (zh) * 2003-10-07 2012-06-27 千年药品公司 用于鉴定、评价、预防和治疗卵巢癌的核酸分子和蛋白质
EP3978929A1 (fr) * 2015-02-19 2022-04-06 Compugen Ltd. Polypeptides pvrig et méthodes de traitement
DK3295951T3 (da) 2015-02-19 2020-07-20 Compugen Ltd Anti-pvrig-antistoffer og fremgangsmåder for anvendelse
MX2019001878A (es) 2016-08-17 2019-07-01 Compugen Ltd Anticuerpos anti-tigit, anticuerpos anti-pvrig y combinaciones de estos.
CA3064331A1 (fr) 2017-06-01 2018-12-06 Compugen Ltd. Therapies a base d'anticorps a triple combinaison

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1007660A2 (fr) * 1997-01-13 2000-06-14 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
EP1007661A2 (fr) * 1997-01-24 2000-06-14 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
US5976837A (en) * 1997-03-14 1999-11-02 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
EP1042674A4 (fr) * 1997-10-24 2005-03-23 Human Genome Sciences Inc 148 proteines humaines secretees

Also Published As

Publication number Publication date
AU3393900A (en) 2000-09-21
EP1165766A2 (fr) 2002-01-02
WO2000052151A2 (fr) 2000-09-08
JP2002537805A (ja) 2002-11-12
WO2000052151A3 (fr) 2001-04-26

Similar Documents

Publication Publication Date Title
CA2417587A1 (fr) Transporteurs et canaux ioniques
CA2353797A1 (fr) Proteines associees a des neurones
US20040248251A1 (en) Receptors and membrane associated proteins
CA2363684A1 (fr) Proteines de secretion humaines
WO2002046415A2 (fr) Transporteurs et canaux ioniques
EP1412387A2 (fr) Transporteurs et circuit ioniques
CA2462795A1 (fr) Proteines secretees
CA2375493A1 (fr) Proteines de transport humaines
CA2405781A1 (fr) Proteines secretees
CA2401113A1 (fr) Transporteurs et canaux ioniques
CA2443897A1 (fr) Transporteurs et canaux ioniques
US20040198651A1 (en) Secreted proteins
JP2005528079A (ja) 分泌タンパク質
CA2438206A1 (fr) Transporteurs et canaux ioniques
CA2404229A1 (fr) Transporteurs et canaux ioniques
WO2000065054A2 (fr) Proteines humaines associees aux membranes
WO2003083085A2 (fr) Canaux ioniques et transporteurs
JP2004528006A (ja) 分泌タンパク質
JP2004523236A (ja) 神経伝達関連タンパク質
CA2394049A1 (fr) Proteines circulant par l'intermediaire de vesicules
US20040087773A1 (en) Molecules for disease detection and treatment
CA2413128A1 (fr) Transporteurs et canaux ioniques
CA2434944A1 (fr) Proteines secretees
CA2437571A1 (fr) Recepteurs et proteines associees aux membranes
CA2437398A1 (fr) Molecules de detection et de traitement de maladies

Legal Events

Date Code Title Description
FZDE Dead